[ad_1]
In the US, $28 Billion is spent annually on epilepsy care yet outcomes have not improved in over 3 decades. The challenge is that clinicians and pharma do not have the tools to effectively measure seizures and side effects. At Eysz, we are building a digital health platform using a person’s eye movements as input to quantitate seizure burden and neurocognitive side effects. We are backed by UCB Pharma, Plug and Play Ventures and have received over $800K in grant funding. So why are we launching an equity crowdfunding campaign? Check out our offering page to find out: https://biovergeportal.com/startups/30-eysz-inc
[ad_2]
Source link